Navigation Links
Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.
Date:12/17/2009

RALEIGH, N.C., Dec. 17 /PRNewswire/ -- Pharmaceutical Institute today announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.

Pharmaceutical Institute is a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance. Financial terms of the agreement were not disclosed.

"We are very pleased with the acquisition of these assets. GeneEd invested more than 10 years and $15 million in their creation, and the content they created is second to none," said John Campbell, CEO of Campbell Alliance. "Over 25 of the world's leading pharma and biotech companies are already using these materials with great success."

As part of the agreement, Pharmaceutical Institute acquired 155 e-courses, including:

  • 135 e-courses in key therapeutic areas, including cardiovascular, diabetes, respiratory, gastrointestinal, muscular skeletal, kidney, infection, oncology, central nervous system, pain and anesthesia, urinary, and metabolism.
  • 12 e-courses in biopharmaceutical technology, including human gene therapy, genomics, combinatorial chemistry, computer-assisted drug design, immunity and disease, bioinformatics, advanced bioinformatics, microarrays, SNPs, methods in microbiology, and microarray informatics.
  • 8 e-courses in clinical trial regulation, including biostatistics, adverse events reporting, good clinical practices, good laboratory practices, and 21 CFR part 11 (electronic records and signatures).

"Pharmaceutical Institute has focused its efforts on building an extensive library of e-course materials for the pharmaceutical and biotech industry. The resources we have acquired from GeneEd are comprehensive and highly technical in nature. This acquisition greatly increases the scope and scale of our distance learning catalog," said Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute.

The training resources acquired from GeneEd will add to Pharmaceutical Institute's already extensive library of training resources that include

  • Understanding Pharma - the most comprehensive introduction to the workings of the pharmaceutical and biotech industry and an end-to-end perspective on the functional areas of a typical biopharmaceutical company
  • Managed Markets Excellence - a comprehensive training solution that addresses the critical need for specialized training in the complex and constantly evolving managed markets environment for pharmaceutical and biologic products

About the Pharmaceutical Institute

Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. We partner with subject matter experts from our parent company, Campbell Alliance, to develop highly-impactful distance learning solutions for professionals within all major pharmaceutical company functions, including Brand Management, Business Development, Clinical Development, Managed Markets, Medical Affairs, Sales, and Trade and Distribution. Pharmaceutical Institute is based in Raleigh, N.C. For more information, please visit www.pharmainstitute.com.

SOURCE Pharmaceutical Institute


'/>"/>
SOURCE Pharmaceutical Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
3. KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
4. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
5. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
6. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
7. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
8. New Report Grades Sustainability Reporting of Top Pharmaceutical Companies
9. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
10. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
11. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):